After-Hours Movers 12/17: (SCS) (CTAS) (NE) Higher; (FIXX) (PACB) (FDX) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cintas (CTAS) PT Raised to $294 at BofA Securities
December 18, 2019 8:47 AM ESTBofA Securities analyst Gary Bisbee raised the price target on Cintas (NASDAQ: CTAS) to $294.00 (from $291.00) while maintaining a Buy rating following results.
Solid Q2 beat and raise, though Rentals slows modestly... MoreNeoleukin Therapeutics (NLTX) Prices 8.925M Share Offering at $8.40/Sh
December 18, 2019 6:09 AM ESTNeoleukin Therapeutics, Inc. (Neoleukin) (NASDAQ: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the pricing of an underwritten public offering of 8,925,000 shares of its common stock at a price to the public of $8.40 per share. The... More
